Understanding how a protein linked to neurodegenerative diseases interacts with cell membranes
Biophysical Determinants of Physiological and Pathological alpha-Synuclein Membrane Interactions
This study is looking at a protein called α-synuclein, which is linked to brain diseases, to understand how it behaves with cell membranes and how changes in its structure might affect its role in these conditions, helping us learn more about neurodegenerative disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10872241 on NIH RePORTER |
What this research studies
This research investigates the behavior of the protein α-synuclein, which is associated with neurodegenerative diseases, particularly how it interacts with cell membranes. By using advanced techniques like deep mutational scanning and nuclear magnetic resonance (NMR) spectroscopy, the researchers aim to uncover the molecular mechanisms that govern the protein's physiological and pathological roles. The study will involve cellular models to observe how changes in the protein's structure affect its function and toxicity. This could lead to insights into the processes that contribute to neurodegenerative disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with neurodegenerative disorders, such as Parkinson's disease, who may benefit from advancements in treatment.
Not a fit: Patients with non-neurodegenerative conditions or those without any neurological disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases by targeting the mechanisms of α-synuclein interactions.
How similar studies have performed: Previous research has shown promising results in understanding protein interactions in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Newberry, Robert William — University of Texas at Austin
- Study coordinator: Newberry, Robert William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.